07.12.2012 Views

financial report and registration document 2011 - Groupe SEB

financial report and registration document 2011 - Groupe SEB

financial report and registration document 2011 - Groupe SEB

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

5 Notes<br />

Consolidated fi nancial statements<br />

to the consolidated fi nancial statements<br />

Maintenance <strong>and</strong> repair costs are expensed as incurred.<br />

The main useful lives are as follows:<br />

� buildings: 10 to 40 years;<br />

� plant <strong>and</strong> machinery: 10 years;<br />

� offi ce equipment: 3 to 10 years;<br />

� vehicles: 4 to 5 years;<br />

� tooling: 1 to 5 years.<br />

Each signifi cant part of an item of property, plant <strong>and</strong> equipment with a useful<br />

life that is different from that of the asset to which it belongs is depreciated<br />

separately. Useful lives are reviewed at regularly intervals <strong>and</strong> the effect of<br />

any adjustments – corresponding to a change in accounting estimates – is<br />

applied prospectively.<br />

No items of property, plant or equipment have been revalued.<br />

In accordance with IAS 17 – Leases, fi nance leases that transfer substantially<br />

all the risks <strong>and</strong> rewards incidental to ownership of an asset to the lessee are<br />

recognised in property, plant <strong>and</strong> equipment for an amount corresponding<br />

to the lower of the fair value of the leased asset <strong>and</strong> the present value of the<br />

minimum lease payments. A liability for the same amount is recorded under<br />

“Finance lease liabilities”.<br />

1.4.3. Impairment of non-current assets<br />

In accordance with IAS 36 – Impairment of Assets, the Group assesses<br />

at the end of each <strong>report</strong>ing period whether there is any indication that its<br />

property, plant <strong>and</strong> equipment <strong>and</strong> intangible assets may be impaired. If any<br />

such indication exists, the assets are tested for impairment. Assets with an<br />

indefi nite useful life – corresponding in the case of <strong>Groupe</strong> <strong>SEB</strong> to goodwill<br />

<strong>and</strong> trademarks – are tested for impairment at least once a year, irrespective<br />

of whether there is any indication of impairment.<br />

Assets with a fi nite useful life are tested whenever events or circumstances<br />

indicate that their carrying amount may not be recovered.<br />

Impairment tests are performed at the level of each Cash-Generating Unit<br />

(CGU). A CGU is defi ned as the smallest identifi able group of assets that<br />

generates cash infl ows that are largely independent of the cash infl ows<br />

from other assets or groups of assets. An impairment loss is recognised<br />

for any excess of an asset’s carrying amount over its recoverable amount.<br />

Recoverable amount corresponds to the higher of the asset’s fair value less<br />

costs to sell <strong>and</strong> its value in use, calculated using the discounted cash fl ows<br />

method. The impairment loss is allocated to reduce the carrying amount of<br />

goodwill <strong>and</strong> then prorata to the other assets of the CGU based on their<br />

respective carrying amounts.<br />

The capitalised amount of development projects in progress is also tested<br />

for impairment.<br />

Impairment losses on CGUs <strong>and</strong> on assets with an indefi nite useful life are<br />

recorded in “Other operating income <strong>and</strong> expense”.<br />

At <strong>Groupe</strong> <strong>SEB</strong>, CGUs correspond to individual production sites, broken<br />

down where appropriate by product family. The assets allocated to<br />

each CGU correspond mainly to tooling <strong>and</strong> other manufacturing assets<br />

(primarily buildings <strong>and</strong> machinery). Marketing subsidiaries <strong>and</strong> integrated<br />

manufacturing <strong>and</strong> sales entities are each treated as separate CGUs, but<br />

marketing subsidiaries that share resources are combined in a single CGU.<br />

Impairment losses recognised for non-fi nancial assets other than goodwill are<br />

reviewed at each annual <strong>and</strong> interim period-end <strong>and</strong> adjusted as necessary.<br />

1.4.4. Financial instruments<br />

Financial instruments are accounted for in accordance with IAS 39 – Financial<br />

Instruments: Recognition <strong>and</strong> Measurement.<br />

Financial assets <strong>and</strong> liabilities are recognised in the balance sheet when<br />

the Group becomes a party to the contractual provisions of the instrument.<br />

They are initially recognised at cost, corresponding to the fair value of the<br />

consideration paid or received plus external transaction costs that are<br />

directly attributable to the acquisition or issue of the fi nancial asset or<br />

fi nancial liability.<br />

A) FINANCIAL ASSETS<br />

Financial assets consist of shares in subsidiaries <strong>and</strong> affi liates, as well as<br />

operating receivables, debt securities <strong>and</strong> other cash equivalents classifi ed<br />

as current assets.<br />

Available-for-sale fi nancial assets are assets that are intended to be held<br />

for an indefi nite period but which may be sold in response to changes in<br />

market interest rates or liquidity needs. They comprise investments in nonconsolidated<br />

companies.<br />

At each period-end, they are measured at fair value <strong>and</strong> the resulting<br />

unrealised gains or losses are recognised directly in equity. When the assets<br />

are sold or there is objective evidence of impairment, the cumulative gains<br />

<strong>and</strong> losses previously recognised in equity are reclassifi ed to profi t.<br />

Held-to-maturity investments are fi nancial assets with a fi xed maturity that<br />

the Group has the positive intention <strong>and</strong> ability to hold to maturity. They are<br />

measured at amortised cost, determined by the effective interest method.<br />

B) FINANCIAL LIABILITIES<br />

Financial liabilities comprise borrowings <strong>and</strong> other fi nancing, including bank<br />

overdrafts <strong>and</strong> operating liabilities.<br />

Borrowings <strong>and</strong> other fi nancial liabilities are measured at amortised cost,<br />

determined by the effective interest method.<br />

When interest rate risks on fi nancial liabilities are hedged by swaps qualifying<br />

as cash fl ow hedges, the swaps are also recognised in the balance sheet at<br />

fair value. The effective portion of changes in their fair value is recognised<br />

directly in equity <strong>and</strong> the ineffective portion is recognised in profi t.<br />

C) DERIVATIVE INSTRUMENTS<br />

Market risks (interest rate, currency <strong>and</strong> commodity price risks) are hedged,<br />

generally through the use of derivative instruments.<br />

In accordance with IAS 32 <strong>and</strong> IAS 39, derivative instruments are measured<br />

at fair value.<br />

The accounting treatment of changes in fair value depends on the future use<br />

of the derivative <strong>and</strong> the resulting accounting classifi cation.<br />

86 GROUPE <strong>SEB</strong> Financial Report <strong>and</strong> Registration Document <strong>2011</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!